This topic contains a solution. Click here to go to the answer

Author Question: The first step in the ABAB design is a. using random assignment to place subjects in groups. b. ... (Read 60 times)

segrsyd

  • Hero Member
  • *****
  • Posts: 530
The first step in the ABAB design is
 
  a. using random assignment to place subjects in groups.
  b. selecting matched pairs for the study.
  c. administering a pretest to all subjects.
  d. measuring the behavior of interest before the treatment.

Question 2

Evidence based on test-criterion relationships may vary from time to time and place to place. Researchers attribute this lack of agreement in validity studies to the
 
  a. type of criterion used.
  b. type of test taker.
  c. way the predictor is measured.
  d. period of time involved.
  e. All of these are true.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

kardosa007

  • Sr. Member
  • ****
  • Posts: 300
Answer to Question 1

D

Answer to Question 2

E




segrsyd

  • Member
  • Posts: 530
Reply 2 on: Jun 20, 2018
Excellent


irishcancer18

  • Member
  • Posts: 310
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

In 1886, William Bates reported on the discovery of a substance produced by the adrenal gland that turned out to be epinephrine (adrenaline). In 1904, this drug was first artificially synthesized by Friedrich Stolz.

Did you know?

About 60% of newborn infants in the United States are jaundiced; that is, they look yellow. Kernicterus is a form of brain damage caused by excessive jaundice. When babies begin to be affected by excessive jaundice and begin to have brain damage, they become excessively lethargic.

Did you know?

Alzheimer's disease affects only about 10% of people older than 65 years of age. Most forms of decreased mental function and dementia are caused by disuse (letting the mind get lazy).

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library